Sukavaneshvar, 2008 - Google Patents
Assessment and management of vascular implant thrombogenecitySukavaneshvar, 2008
- Document ID
- 14317494143019564560
- Author
- Sukavaneshvar S
- Publication year
- Publication venue
- Thrombus and Stroke. New York, NY: Informa Health Care
External Links
Snippet
Vascular implants such as stents and coils have been used successfully to treat diseases such as atherosclerosis and aneurysms (1-3). These devices, however, carry the risk of thrombosis, which warrants consideration during device design and during clinical …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fink et al. | Real-time measurements of coagulation on bacterial cellulose and conventional vascular graft materials | |
| Chinn et al. | Baboon fibrinogen adsorption and platelet adhesion to polymeric materials | |
| JP2021012207A (en) | Detection and classification of anticoagulant using clotting assay | |
| US10830683B2 (en) | Method for measuring coagulation of blood samples using viscoelastic tests (VET) | |
| Lasne et al. | A Study of Platelet Functions with a New Analyzer Using High Shear Stress (PFA100™) in Patients Undergoing Coronary Artery Bypass Graft | |
| US20050196748A1 (en) | Method and device for monitoring platelet function | |
| Grunkemeier et al. | Co-adsorbed fibrinogen and von Willebrand factor augment platelet procoagulant activity and spreading | |
| Kottke‐Marchant et al. | Vascular graft‐associated complement activation and leukocyte adhesion in an artificial circulation | |
| Braune et al. | Developing standards and test protocols for testing the hemocompatibility of biomaterials | |
| Sperling et al. | Test methods for hemocompatibility of biomaterials | |
| McKenzie et al. | Clinical utility of available methods for determining platelet function | |
| Mrowietz et al. | Haemocompatibility of polymer‐coated stainless steel stents as compared to uncoated stents | |
| Massicotte et al. | Antithrombotic therapy for ventricular assist devices in children: do we really know what to do? | |
| US10012659B2 (en) | Methods for diagnosing iron-related pathologies | |
| Bauer et al. | Influence of blood collection technique on platelet function and coagulation variables in dogs | |
| US20050019742A1 (en) | Methods for assessment of platelet aggregation | |
| Sukavaneshvar | Assessment and management of vascular implant thrombogenecity | |
| Krajewski et al. | Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation | |
| Wakhloo et al. | Assessment and Management of Vascular Implant Thrombogenecity...................................... Sivaprasad Sukavaneshvar | |
| Patel et al. | Molecular biomarkers for In vitro thrombogenicity assessment of medical device materials | |
| Abe et al. | Correlation between platelet thrombus formation on collagen-coated beads and platelet aggregation induced by ADP | |
| Berkowitz et al. | Progress in point-of-care laboratory testing for assessing platelet function | |
| Adams | Platelet adhesion: past and present | |
| JP4833727B2 (en) | Thrombus monitoring method and thrombus monitoring apparatus using vascular endothelial cells | |
| Mischke | Laboratory evaluation and interpretation of haemostasis in small animals |